Background {#Sec1}
==========

Mammographic density remains one of the strongest predictors of breast cancer risk among women in the general population \[[@CR1]\]. Women with high percent density (≥75% density) have an estimated 4.6-fold increased risk of breast cancer compared to women with low percent density (\<5% density) \[[@CR1]\]. While the biological basis underlying this relationship is unclear, high mammographic density may reflect the cumulative exposure of the dense breast stroma and epithelium to hormonal and growth factors, which can stimulate their proliferation and lead to carcinogenesis \[[@CR2], [@CR3]\]. A family history of breast cancer, which is also a strong risk factor for the disease, has been shown to be associated with higher mammographic density in addition to greater breast cancer risk \[[@CR4]--[@CR6]\].

Along with family history, several reproductive, hormonal and lifestyle risk factors for breast cancer are also associated with mammographic density, suggesting that mammographic density may mediate the relationships between some of these risk factors and breast cancer risk \[[@CR2], [@CR7]\]. To our knowledge, there is very little literature evaluating whether breast cancer risk factors are associated with mammographic density among high-risk populations, including no studies among *BRCA* mutation carriers and only one study among women with a family history \[[@CR8]\].

Therefore, it is not established whether the reproductive, hormonal, and lifestyle breast cancer risk factors that modify mammographic density in the general population are applicable to women with a strong family history of breast cancer. Given the evidence suggesting that mammographic density is strongly implicated in familial breast cancers \[[@CR4]--[@CR6], [@CR8]\], evaluating whether these risk factors are associated with mammographic density may help explain the underlying mechanisms mediating their relationships with breast cancer risk among high-risk women. Thus, the goal of the current study was to evaluate the relationship between various reproductive, hormonal, and lifestyle risk factors with three measures of mammographic density (e.g., percent density, dense area, and non-dense area), among women with a strong family history of disease but no *BRCA* mutation.

Methods {#Sec2}
=======

Study Population {#Sec3}
----------------

Potentially eligible subjects were identified from a longitudinal prospective cohort study of women with a strong family history of breast cancer but no identified *BRCA* mutation, based at Women's College Hospital (Toronto, Canada) and previously described in detail \[[@CR9]\]. *BRCA* mutation detection in the affected relatives was performed using a variety of genetic testing methodologies, as techniques have evolved over time, but all nucleotide sequences were confirmed by Sanger direct sequencing. Pedigrees were retrospectively reviewed to identify families that met the eligibility criteria. The probands (i.e., the first family member to undergo genetic testing) of the eligible families were invited to share the study information with their cancer-free, first-degree relatives.

Participants were recruited from six genetic counselling clinics in Ontario. Participants were eligible if 1) there was no *BRCA* mutation found in their affected relatives; 2) they had a strong family history of breast cancer; and 3) they had no personal history of cancer or a prophylactic bilateral mastectomy prior to enrollment. A strong family history entailed two breast cancers in first-degree relatives under the age of 50, or three cases of breast cancer at any age on the paternal or maternal side of the family. This study was approved by the institutional ethics review boards of the six collaborating institutions and all participants provided written informed consent.

Data Collection {#Sec4}
---------------

Upon enrollment into the overarching cohort study, participants complete a self-administered baseline research questionnaire, a Diet History Questionnaire (DHQ) \[[@CR10]\], and biological samples were collected \[[@CR9]\]. Participants signed a medical release form for review of their breast imaging and pathology reports. A follow-up questionnaire was mailed biennially to all subjects in order to update their personal medical histories and to ascertain incident disease.

The research questionnaires collected detailed information regarding family history, reproductive histories, preventive surgeries and breast screening, and lifestyle factors such as physical activity, smoking and alcohol consumption. Specifically, the questionnaires inquired about parity (number of live births), duration of breastfeeding, exogenous hormone use (oral contraceptives and hormone replacement therapy), height and weight, the average number of alcoholic drinks consumed per week (0-3, 4-9, 10-20 and 20 or more), and smoking history (number of packs of cigarettes smoked per week). 'Ever' alcohol drinkers were defined as those who reported consuming at least one alcoholic beverage within the last six months.

Briefly, physical activity was ascertained using a check-list originally developed for the Nurses' Health Study \[[@CR11]\] and has been previously validated \[[@CR12]\]. Participants reported the length of time (ranging from 0 to ≥11 hours) they spent engaged in various physical activities per week during the last 12 months, including: walking, jogging, swimming, tennis, aerobics and weight lifting. A Metabolic Equivalent of Task (MET) score was assigned to each physical activity to describe its intensity, using criteria established by Ainsworth *et al.,* \[[@CR13]\]. MET values for walking were determined based on the reported walking pace (average: 3.0 METs). A total weekly activity score was calculated by summing all MET values for each participant. In order to investigate the independent effect of moderate-to-vigorous physical activity (MVPA), a second physical activity score, that included only activities at the moderate and vigorous intensity levels, was also created.

Subjects Available for Analyses {#Sec5}
-------------------------------

Women were included in the current study if they were between the ages of 18-65 years at enrollment and reported undergoing at least one mammogram. Medical release forms were used to obtain mammographic images. For women who reported undergoing mammography at their baseline research questionnaire, the mammogram closest to the completion date of this questionnaire was requested. For participants who had their first mammogram after their baseline questionnaire, the follow-up questionnaire closest in time to this mammogram was requested. Of the 191 participants who reported having at least one mammogram, mammographic images from 168 participants were successfully obtained. Mammograms that were not compatible with the Cumulus software due to compressed formatting were excluded (n = 11), thus 157 participants were included in the final analysis. Only screening mammograms were requested, thus, none of the participants had a breast cancer diagnosis at the time of, or prior to, the mammograms used in this analysis. The majority of women (n = 131) had undergone mammography at the time of their baseline questionnaire. Follow-up questionnaires were used for women who initiated mammography screening after the completion of their baseline questionnaire (First follow-up: n = 17; Second follow-up: n = 8; Third follow-up: n = 1).

Mammographic Density Assessment {#Sec6}
-------------------------------

The Cumulus software (University of Toronto, Toronto, Canada) was used to quantify mammographic density. Cumulus is a semi-automated, computer-assisted thresholding method and is the gold standard for mammographic density assessment \[[@CR14]\]. Mammographic density is strongly correlated between breasts \[[@CR15]\], thus the cranio-caudal view of the right breast of each subject was used to measure percent density. To determine the dense area and non-dense area, the pixel spacing of each image (range: 49 to 252 μm/pixel) was converted into centimetres squared (cm^2^) to determine the area of each pixel. Next, the dense area and total breast area were multiplied by the pixel area. The non-dense area was determined by subtracting the dense area by the total breast area. Thirteen of the 157 mammographic images were films, and nine were previously digitized by the original imaging centres. The remaining four films were digitized by the study team using a pixel spacing of 252 μm/pixel and the iCAD scanner and Fulcrum software.

The mammographic images were read in three batches by two readers. Reader 1 (MY) read Batch 1 and Batch 2 (number of images \[n\] Batch 1: n = 61; Batch 2: n = 39) and Reader 2 (OM) read Batch 3 (n = 57). In all three batches, the images were randomized and 15% of the images were randomly repeated. There was high reproducibility within each batch, yielding a mean within-batch correlation coefficient of 0.91. For all images that were repeated, the average value of the mammographic density measures were used. An accurate pixel size could not be obtained for a subset of the images (n = 13), thus dense area and non-dense area could not be assessed.

Statistical Analyses {#Sec7}
--------------------

All exposures were analyzed continuously and dichotomously *a priori* using high vs. low categories based on the median distribution in the cohort. The 75^th^ percentile was used for the anthropometric variables because of their strong correlation with mammographic density. Given the low levels of physical activity in this group of women, the 75^th^ percentiles for the physical activity variables were used to maximize the investigation of high physical activity and mammographic density. Percent density, dense area, and non-dense area were non-normally distributed; therefore, all values were square root-transformed to improve normality. We excluded one postmenopausal woman with a percent density value of 77.2%, since it was four standard deviations above the mean. Thus, 59 postmenopausal women were included in the analyses.

Analyses were stratified by menopausal status *a priori* because mammographic density declines after menopause \[[@CR3]\]. Differences in descriptive characteristics were evaluated using the Student's *t*-test for continuous variables and the χ^2^-square test for categorical variables. Generalized linear models were used to obtain the β-estimates, least-square adjusted means, and the 95% confidence intervals (CI) of percent density, dense area, and non-dense area. The least-square adjusted means and corresponding 95% CI were back-transformed to facilitate interpretation of findings. All models adjusted for age and BMI at the time of the mammogram and parity. Since the mammograms came from different sources, all models were adjusted for modality (digital mammograms, films digitized by the original imaging centers, and films digitized by the study team). The models for total live births and breastfeeding were further adjusted for age at first live birth. The height and weight models were mutually adjusted for each other instead of BMI. The physical activity and alcohol models were additionally adjusted for smoking status (never, former, current). The smoking models were additionally adjusted for alcohol consumption (drinks per week). Single imputation was performed for missing quantitative data points by imputing the median value of the exposure. This was done for age at menarche (number of missing data points \[n\] = 2) and age at first use of alcohol (n = 1). For any missing qualitative data (i.e., never/ever), we attempted to contact study subjects to retrieve the missing information, after which any remaining data was left as missing. Analyses were conducted using SAS version 9.3 (SAS Institute, Cary, NC, USA).

All *P* values were based on two-sided tests. We applied the Bonferroni correction to account for the multiple comparisons and given that some comparisons involved groups with counts less than five (*P* ≤ 0.0002, based on 222 tests and α = 0.05). This calculation includes the statistical analyses performed in the Additional file [1](#MOESM1){ref-type="media"}: Table S1, Additional file [2](#MOESM2){ref-type="media"}: Table S2, Additional file [3](#MOESM3){ref-type="media"}: Table S3, and Additional file [4](#MOESM4){ref-type="media"}: Table S4.

Results {#Sec8}
=======

A total of 97 premenopausal and 59 postmenopausal women were included in the current study (Table [1](#Tab1){ref-type="table"}). Postmenopausal women were older (*P* \<0.0001), had a lower mean percent density (*P* \<0.0001), a lower mean absolute dense area (*P* = 0.0001), and a greater mean non-dense area (*P* = 0.04) compared to premenopausal women. On average, postmenopausal women had a greater mean number of live births (2.3 births vs. 1.9 births; *P* = 0.005) and were younger at their first live birth compared to premenopausal women (25.5 years vs. 30.2 years; *P* \<0.0001). Among smokers, postmenopausal women smoked a greater number of packs of cigarettes per week compared to premenopausal women (4.2 packs vs. 2.8 packs; *P* = 0.01).Table 1Characteristics at baseline of study population stratified by menopausal statusCharacteristicPremenopausal Women\
*N* = 97Postmenopausal Women\
*N* = 59Age at questionnaire, mean (range)43.3 (27.0-58.3)56.6 (43.2-68.3)Age at mammogram, mean (range)43.9 (29.2-59.0)56.5 (41.8-68.2)Years between questionnaire and mammogram, mean (range)0.9 (0-5.6)0.6 (0-2.0)Percent Density (%), mean (range)27.5 (0.2-79.7)14.0 (0.7-58.3)Dense Area (cm^2^), mean (range)33.2 (0.6-152.8)18.4 (1.6-111.8)Non-Dense Area (cm^2^), mean (range)116.1 (16.6-496.1)143.0 (50.7-348.5)Height (cm), mean (range)166.5 (149.9-188.0)164.0 (152.0-175.3)BMI (kg/m^2^), mean (range) Current25.8 (18.0-48.0)26.7 (18.4-42.0) At 18 years21.4 (15.7-44.3)20.4 (16.9-26.6) At 30 years23.7 (18.0-46.3)22.3 (17.7-34.9) At 40 years24.3 (18.8-42.9)24.2 (17.7-38.6) Greatest BMI27.2 (18.3-49.6)28.5 (20.6-42.0)Age at menarche, mean (range)12.8 (8.0-16.0)13.1 (11.0-16.0)Parity^1^, *n* (%)71 (73)46 (77)Nulliparous26 (27)14 (23)121 (30)6 (13)235 (49)22 (48)≥315 (21)18 (39)Mean (range)1.9 (1-3)2.3 (1-4)Age at first birth, mean (range)30.2 (18.0-42.0)25.5 (15.0-37.0)Breastfeeding, mean months (range)^2^15.1 (0-87)9.3 (0-39)Age at menopause,^3^ mean (range)N/A46.4 (26-56)Hormone therapy use, *n* (%)^3^ NeverN/A43 (73) Ever16 (27) Years of HRT use, mean (range)6.8 (0.3-23.0)Oral contraceptive use, *n* (%) Never10 (10)5 (9) Ever87 (90)53 (91) Missing01 (2) Years of OC use, mean (range)9.6 (0.5-34.0)9.6 (0.08-30.0)Alcohol use, *n* (%) Never10 (10)5 (8) Ever87 (90)55 (92) Current73 (79)46 (84) Drinks consumed per week, mean (range)3.9 (2-15)4.7 (2-20) Age of initiation, mean (range)18.2 (14.0-30.0)18.8 (13.0-40.0)Smoking history, *n* (%) Never64 (66)30 (51) Ever33 (34)29 (49) Current7 (20)7 (22) Number of packs smoked per week, mean (range)2.8 (1-7)4.2 (1-9) Age of initiation, mean (range)17.4 (13.0-29.0)16.1 (11.0-23.0)Physical Activity Within the last year Total physical activity MET^4^-hours per week, mean (range)36.2 (0-162.6)30.5 (0-211.0) MVPA^5^ MET-hours per week, mean (range)23.3 (0-147.6)19.1 (0-141.0)^1^Parity includes live births only^2^Among parous women only^3^Among postmenopausal women only^4^Metabolic Equivalent of Task. Includes walking and moderate and vigorous physical activity^5^Moderate to vigorous physical activity

Overall, the mean time difference between the mammogram and the questionnaire used was 0.9 years (range: 0-5.6 years) for premenopausal women and 0.6 years (range: 0-2.0 years) for postmenopausal women (*P* = 0.01). No other differences were observed between the two groups (*P* ≥ 0.06).

Reproductive and Hormonal Risk Factors {#Sec9}
--------------------------------------

Among parous premenopausal women (n = 71), increasing number of live births was modestly associated with lower percent density (β = -0.60; 95% CI -1.26, 0.06; *P* = 0.07) (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Women who had two live births had an adjusted mean percent density of 28.8% compared to 41.6% among women who had one live birth (*P* = 0.04) (Table [2](#Tab2){ref-type="table"}). Among parous postmenopausal women (n = 46), women who had two or more live births had higher adjusted mean non-dense areas of 143.0 cm^2^ and 146.4 cm^2^, respectively, compared to 95.1 cm^2^ among women who had one live birth (both *P* = 0.04) (Table [3](#Tab3){ref-type="table"}). No other significant associations were observed between the reproductive and hormonal exposures among premenopausal or postmenopausal women (*P* ≥ 0.06) (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}**,** Additional file [1](#MOESM1){ref-type="media"}: Table S1 and Additional file [2](#MOESM2){ref-type="media"}: Table S2).Table 2Adjusted mean mammographic density measures according to reproductive and hormonal exposures among premenopausal womenPremenopausal women (*n* = 97)Percent Density (%)Dense Area (cm^2^)Non-Dense Area (cm^2^)*n*Mean^1^ PD95% CI^1^*P* ^*1*^*n*Mean^1^ DA95% CI^1^*P* ^*1*^*n*Mean^1^ NDA95% CI^1^*P* ^*1*^Age at menarche \<13 years3229.920.0-41.82831.117.2-49.22880.150.4-116.7 ≥13 years6528.219.6-38.30.696035.322.5-51.10.496098.269.8-131.60.16Parity Nulliparous2632.521.5-45.82337.121.4-57.02393.660.5-133.8 Parous7128.119.7-38.10.336533.821.3-49.20.616593.966.1-126.60.98Total live births^2^ 12141.627.2-59.0ref1950.128.0-78.6ref1971.739.0-114.3ref 23528.817.8-42.30.043232.917.2-53.70.063284.752.2-125.00.40 ≥31529.115.3-47.30.121433.013.7-60.80.141482.542.6-135.30.58Breastfeeding^2^ Never434.913.2-67.0444.113.7-91.8477.926.9-155.3 Ever6631.720.7-45.10.796136.019.8-56.90.646181.550.7-119.60.90Breastfeeding duration^2^ \<11 months3032.718.7-50.53141.921.2-69.63176.541.4-122.4 ≥11 months4031.720.6-45.20.873434.918.9-55.80.433482.851.3-121.80.69OC use Never1029.617.5-44.9933.215.8-57.1972.438.4-117.2 Ever8728.519.9-38.70.877934.521.9-50.00.897997.369.1-130.30.18Duration of OC use \<9 years4037.425.2-52.03741.524.6-62.83779.950.0-116.8 ≥9 years4733.022.1-46.00.324235.920.4-55.90.394286.154.9-124.20.60^1^Adjusted least-square means, 95% confidence intervals, and *P*-values are from analyses using square root-transformed mammographic density measures. The adjusted least-square means and 95% confidence intervals were back-transformed^2^Among parous women onlyAll models were adjusted for age (continuous) and BMI (continuous) at the time of mammogram, parity (continuous), and mammogram modality (digital image, film scanned by study team, film scanned by imaging centre). The parity (total live births) and breastfeeding models were additionally adjusted for age at first birth (continuous). OC, oral contraceptivesTable 3Adjusted mean mammographic density measures according to reproductive and hormonal exposures among postmenopausal womenPostmenopausal women (*n* = 59)Percent Density (%)Dense Area (cm^2^)Non-Dense Area (cm^2^)*n*Mean^1^ PD95% CI^1^*P* ^*1*^*n*Mean^1^ DA95% CI^1^*P* ^*1*^*n*Mean^1^ NDA95% CI^1^*P* ^*1*^Age at menarche \<13 years2114.38.7-21.21818.010.8-27.018121.692.3-154.9 ≥13 years3813.88.6-20.20.853721.714.2-30.80.3637133.0104.3-165.30.44Parity Nulliparous1317.410.3-26.21124.915.1-37.111120.086.8-158.6 Parous4613.58.6-19.40.244419.412.7-27.50.2544128.1101.4-158.00.63Total live births^2^ 1621.311.7-33.8ref629.417.8-44.0ref695.159.5-139.1ref 22212.97.0-20.40.092019.512.0-28.90.1120143.0106.9-184.30.04 ≥31812.86.4-21.50.111820.912.3-31.60.1918146.4106.4-192.90.04Breastfeeding^2^ Never1014.16.3-25.01026.415.2-40.610154.9106.5-212.4 Ever3514.28.3-21.80.973420.913.5-29.80.2934129.697.0-166.80.25Breastfeeding duration^2^ \<11 months2612.96.9-20.82420.912.8-31.124148.8110.8-192.5 ≥11 months2015.88.9-24.70.412022.714.2-33.30.6920119.885.8-159.40.12OC use Never59.02.6-19.3416.45.5-33.24149.494.9-216.2 Ever5313.99.2-19.70.245020.113.4-28.10.5950128.9103.3-157.30.45Duration of OC use \<9 years2614.69.0-21.52619.912.4-29.226120.593.5-151.0 ≥9 years2712.97.6-19.60.552420.112.3-29.80.9524140.6110.3-174.60.16HRT use Never4313.78.7-19.7ref3919.913.1-28.1ref39133.0106.5-162.5ref Former914.87.2-25.00.77919.19.4-32.10.889100.466.3-141.50.08 Current716.17.4-28.20.60724.011.7-40.80.527123.880.7-176.10.68^1^Adjusted least-square means, 95% confidence intervals, and *P*-values are from analyses using square root-transformed mammographic density measures. The adjusted least-square means and 95% confidence intervals were back-transformed^2^Among parous women onlyAll models were adjusted for age (continuous) and BMI (continuous) at the time of mammogram, parity (continuous), and mammogram modality (digital image, film scanned by study team, film scanned by imaging centre).The parity (total live births) and breastfeeding models were additionally adjusted for age at first birth (continuous). OC, oral contraceptives. HRT, hormone replacement therapy

Anthropometric Risk Factors {#Sec10}
---------------------------

Among premenopausal women, an increasing body weight was associated with significantly lower percent density (β = -0.05; 95% CI -0.07, -0.03; *P* \<0.0001) and significantly greater non-dense area (β = 0.13; 95% CI 0.09, 0.17; *P* \<0.0001) (Additional file [3](#MOESM3){ref-type="media"}: Table S3). Women with a high body weight had a significantly lower adjusted mean percent density (17.6% vs. 33.2%; *P* = 0.0006) and a significantly greater adjusted mean non-dense area (165.2 cm^2^ vs. 73.2 cm^2^; *P* \<0.0001) than women with a low body weight (Table [4](#Tab4){ref-type="table"}). Increasing height was associated with significantly lower non-dense area (β = -0.12; 95% CI -0.21, -0.03; *P* = 0.01) (Additional file [3](#MOESM3){ref-type="media"}: Table S3). Among postmenopausal women, an increasing body weight was associated with lower percent density (β = -0.05; 95% CI -0.07, -0.02; *P* = 0.001) and higher non-dense area (β = 0.13; 95% CI 0.08, 0.18; *P* \<0.0001) (Additional file [4](#MOESM4){ref-type="media"}: Table S4). Women with a high body weight had a significantly lower adjusted mean percent density (8.7% vs. 14.7%; *P* = 0.04) and a greater adjusted mean non-dense area (184.8 cm^2^ vs. 117.4 cm^2^; *P* = 0.0007) compared to women with a low body weight (Table [5](#Tab5){ref-type="table"}). Women with a greater height had a significantly lower adjusted mean non-dense area of 98.3 cm^2^ compared to 137.3 cm^2^ among women with a lower height (*P* = 0.01) (Table [5](#Tab5){ref-type="table"}).Table 4Adjusted mean mammographic density measures according to anthropometric and lifestyle factors among premenopausal womenPremenopausal women (*n* = 97)Percent Density (%)Dense Area (cm^2^)Non-Dense Area (cm^2^)*n*Mean^1^ PD95% CI^1^*P* ^*1*^*n*Mean^1^ DA95% CI^1^*P* ^*1*^*n*Mean^1^ NDA95% CI^1^*P* ^*1*^Weight \<77.0 kg7133.223.7-44.26435.322.4-51.16473.247.6-104.4 ≥77.0 kg2617.69.4-28.40.00062431.917.1-51.40.5924165.2115.9-223.2\<0.0001Height \<170 cm6927.018.3-37.56332.419.2-48.96397.766.5-135.0 ≥170 cm2833.223.1-45.10.182537.023.1-54.30.472578.651.3-111.80.16TWA \<43.0 MET-hrs/week6926.417.1-37.86230.617.4-47.56394.663.0-132.6 ≥43.0 MET-hrs/week2824.114.6-36.00.582629.815.7-48.20.882593.959.8-135.60.96MVPA \<27.0 METs/week7226.117.1-37.06430.217.3-46.66493.963.0-131.0 ≥27.0 METs/week2523.613.6-36.30.552430.716.0-50.10.932495.660.2-139.30.90Smoking status Never6428.920.3-39.1ref5833.520.8-49.3ref5889.561.4-122.9ref Former2629.319.3-41.50.932336.221.5-54.80.6823102.468.7-142.90.36 Current smoker718.16.8-34.90.14719.75.2-43.50.15787.742.3-149.30.94Age at first use \<16 years1019.87.3-38.31030.012.3-55.410130.478.6-195.3 ≥16 years2328.814.0-49.00.152046.725.0-75.10.0720127.979.8-187.40.90Packs smoked \<3 packs/week2029.214.4-49.31848.127.5-74.518125.578.4-183.6 ≥3 packs/week1319.57.3-37.60.121225.510.0-48.20.0112135.981.7-203.80.64Duration of use \<14 years1632.217.4-51.31453.132.0-79.514126.077.5-186.3 ≥14 years1715.85.6-31.20.011625.311.0-45.50.00216132.780.6-197.80.76Alcohol use Never1029.717.4-45.1ref938.118.9-63.8ref9103.361.0-156.6ref Former1530.518.1-46.20.911532.816.4-54.70.641579.745.8-122.90.31 Current user7227.919.1-38.30.786433.821.0-49.70.666496.067.3-129.70.73Age at first use \<18 years2921.511.8-34.22728.915.2-47.027118.878.4-167.6 ≥18 years5827.517.7-39.30.145234.321.0-51.00.345290.660.1-127.40.05Drinks consumed \<2 drinks/week6025.215.4-37.45733.019.1-50.75792.559.0-133.4 ≥2 drinks/week2727.717.0-41.10.582233.219.0-51.30.9822101.165.3-144.60.58^1^Adjusted least-square means, 95% confidence intervals, and *P*-values are from analyses using square root-transformed mammographic density measures. The adjusted least-square means and 95% confidence intervals were back-transformedAll models were adjusted for age (continuous) and BMI (continuous) at the time of mammogram, parity (continuous), and mammogram modality (digital image, film scanned by study team, film scanned by imaging centre). The height and weight models were mutually adjusted for each other (continuous) instead of BMI. The physical activity models were additionally adjusted for smoking status (never, former, current). The smoking models were additionally adjusted for the number of alcoholic drinks consumed per week (continuous). The alcohol models were additionally adjusted for smoking status (never/ever). TWA, total weekly activity. MVPA, moderate-to-vigorous physical activity. METs, Metabolic Equivalent of TaskTable 5Adjusted mean mammographic density measures according to anthropometric and lifestyle factors among postmenopausal womenPostmenopausal women (*n* = 59)Percent Density (%)Dense Area (cm^2^)Non-Dense Area (cm^2^)*n*Mean^1^ PD95% CI^1^*P* ^*1*^*n*Mean^1^ DA95% CI^1^*P* ^*1*^*n*Mean^1^ NDA95% CI^1^*P* ^*1*^Weight \<77.0 kg4314.79.3-21.54019.412.4-27.840117.488.0-151.0 ≥77.0 kg168.74.2-14.80.041518.711.3-28.10.8815184.8143.4-231.40.0007Height \<170 cm4713.48.8-19.14320.313.8-28.243137.3111.7-165.6 ≥170 cm1215.48.2-24.70.561218.39.4-30.00.631298.366.9-135.70.01TWA \<43.0 MET-hrs/week4913.78.7-19.74518.912.1-27.245123.596.3-154.1 ≥43.0 MET-hrs/week1012.76.4-21.00.761019.510.4-31.60.8810148.7108.4-195.30.16MVPA \<27.0 METs/week4512.47.6-18.34117.010.5-25.141128.899.4-162.1 ≥27.0 METs/week1415.89.5-23.60.251423.114.3-33.90.1414126.593.3-164.70.88Smoking status Never3010.86.5-16.1ref2916.410.3-23.9ref29138.6110.4-170.1ref Former2219.513.2-27.00.0032026.918.1-37.40.0120108.481.1-139.80.04 Current smoker710.84.5-19.90.996145.4-26.40.626134.089.4-187.70.84Age at first use \<16 years1420.59.7-35.31232.015.9-53.61291.247.1-149.8 ≥16 years1526.214.8-40.80.351436.921.9-55.80.5814111.368.8-163.90.42Packs smoked \<3 packs per week818.87.9-34.3735.017.0-59.47126.270.7-197.7 ≥3 packs per week2125.114.7-38.30.261935.221.3-52.70.9819100.863.2-1470.28Duration of use \<14 years1324.312.1-40.81137.520.1-60.311121.771.0-186.1 ≥14 years1623.813.3-37.30.911534.520.5-52.00.701598.961.1-145.80.30Alcohol use Never516.87.6-29.6ref423.29.8-42.3ref4102.659.0-158.3ref Former816.98.1-28.90.99822.911.0-39.10.988108.568.6-157.50.83 Current user4614.19.4 19.80.584320.413.7-28.40.7043128.7103.1-157.10.30Age at first use \<18 years2012.16.9-18.81717.710.2-27.217138.9106.0-176.2 ≥18 years3415.19.7-21.70.293422.314.8-31.50.2634122.695.4-153.20.30Drinks consumed \<2 drinks per week3513.48.3-19.73319.112.2-27.633120.493.8-150.3 ≥2 drinks per week1914.98.8-22.50.621823.414.6-34.30.3218143.5110.2-181.20.14^1^Adjusted least-square means, 95% confidence intervals, and *P*-values are from analyses using square root-transformed mammographic density measures. The adjusted least-square means and 95% confidence intervals were back-transformedAll models were adjusted for age (continuous) and BMI (continuous) at the time of mammogram, parity (continuous), and mammogram modality (digital image, film scanned by study team, film scanned by imaging centre). The height and weight models were mutually adjusted for each other (continuous) instead of BMI. The physical activity models were additionally adjusted for smoking status (never, former, current). The smoking models were additionally adjusted for the number of alcoholic drinks consumed per week (continuous). The alcohol models were additionally adjusted for smoking status (never/ever). TWA, total weekly activity. MVPA, moderate-to-vigorous physical activity. METs, Metabolic Equivalent of Task

Lifestyle Risk Factors {#Sec11}
----------------------

Among premenopausal women who reported ever smoking (n = 33), increasing age of smoking initiation was associated with greater dense area (β = 0.30; 95% CI 0.08, 0.53; *P* = 0.01) (Additional file [3](#MOESM3){ref-type="media"}: Table S3). Increasing number of packs of cigarettes smoked per week was associated with significantly lower dense area (β = -0.41; 95% CI -0.77, -0.05; *P* = 0.03) (Additional file [3](#MOESM3){ref-type="media"}: Table S3). Further, those who reported smoking at least three cigarette packs per week had a lower adjusted mean dense area of 25.5 cm^2^ compared to 48.1 cm^2^ among women who smoked fewer packs per week (*P* = 0.01) (Table [4](#Tab4){ref-type="table"}). Increasing duration of smoking was associated with significantly lower percent density (β = -0.07; 95% CI -0.13, -0.01; *P* = 0.02) and lower dense area (β = -0.12; 95% CI -0.18, -0.07; *P* = 0.0002) (Additional file [3](#MOESM3){ref-type="media"}: Table S3). Women who reported smoking for at least 14 years had a significantly lower adjusted mean percent density (15.8% vs. 32.3%; *P* = 0.01) and an adjusted mean dense area (25.3 cm^2^ vs. 53.1 cm^2^; *P* = 0.002) compared to women who smoked for a shorter duration (Table [4](#Tab4){ref-type="table"}).

Among postmenopausal women who reported ever smoking (n = 29), former smokers had a significantly greater adjusted mean percent density (19.5% vs. 10.8%; *P* = 0.003), a greater adjusted mean dense area (26.9 cm^2^ vs. 16.4 cm^2^; *P* = 0.01) and a lower adjusted mean non-dense area (108.4 cm^2^ vs. 138.6 cm^2^; *P* = 0.04) compared to never smokers (Table [5](#Tab5){ref-type="table"}). When this model was run continuously, former smokers were found to have significantly higher percent density (β = 1.13; 95% CI 0.41, 1.84; *P* = 0.003), higher dense area (β = 1.13; 95% CI 0.26, 2.00; *P* = 0.01), and lower non-dense area (β = -1.36; 95% CI -2.68, -0.04; *P* = 0.04) compared to never smokers (Additional file [4](#MOESM4){ref-type="media"}: Table S4).

Among premenopausal women, increasing age of first use of alcohol was associated with significantly higher percent density (β = 0.16; 95% CI 0.02, 0.31; *P* = 0.03) and dense area (β = 0.23; 95% CI 0.06, 0.40; *P* = 0.01) (Additional file [3](#MOESM3){ref-type="media"}: Table S3). Among postmenopausal women, increasing age of first use of alcohol was associated with higher percent density (β = 0.11; 95% CI 0.03, 0.19; *P* = 0.01) and dense area (β = 0.16; 95% CI 0.07, 0.25; *P* = 0.0006) (Additional file [4](#MOESM4){ref-type="media"}: Table S4).After applying the Bonferroni correction (new significance level: *P* ≤ 0.0002), the inverse associations between body weight and percent density and dense area remained significant among premenopausal women (*P* \<0.0001 each). Among both premenopausal and postmenopausal women, the positive association between body weight and non-dense area remained significant (*P* \<0.0001 each). In premenopausal women, the inverse association between duration of smoking and dense area remained significant (*P* = 0.0002). All other findings were non-significant based on the corrected *P-*value.

Discussion {#Sec12}
==========

In this cross-sectional analysis of women with a strong family history of breast cancer and no *BRCA* mutation, various exposures were associated with mammographic density; although not all associations were in the directions that were previously reported among the general population. These findings suggest that mammographic density may act as an intermediate factor in the pathway between some of these risk factors and their influence on breast cancer risk in this cohort, particularly, parity, premenopausal body weight, and height. Although we examined a specific cohort of women, these results suggest similar mechanisms may mediate the relationships between some breast cancer risk factors and disease among this cohort and among the general population.

Parity was significantly associated with lower mammographic density among both premenopausal and postmenopausal women. These findings suggest that parity is associated with changes in both the dense and non-dense areas of the breast, and that mammographic density may mediate the influence of parity on breast cancer risk in this cohort. Parity is an established protective factor for breast cancer, and is thought to exert this effect on breast cancer risk by reducing the pool of mammary stem cells that are susceptible to genetic change \[[@CR16], [@CR17]\]. This biological hypothesis may explain why parous women typically have lower percent density compared to nulliparous women in the general population \[[@CR17]\], as well as in our study population.

In the general population, a high body size is protective against breast cancer in premenopausal women, but is positively associated with breast cancer risk in postmenopausal women \[[@CR18], [@CR19]\]. Despite this paradoxical relationship, body size is inversely associated with percent mammographic density due to a positive association with non-dense area in both premenopausal and postmenopausal women \[[@CR18]\]. Adiposity may result in an increased risk of breast cancer among postmenopausal women, where it is the primary source of endogenous estrogens, by stimulating the proliferation of dense epithelial cells in the breast \[[@CR18], [@CR20]\]. In the current study, body weight was inversely associated with percent mammographic density and positively associated with non-dense area among both premenopausal and postmenopausal women. These findings suggest that mammographic density may mediate the association between body weight and breast cancer in premenopausal women, but it likely does not mediate this association in postmenopausal women.

A greater adult attained height has previously been shown to be positively associated with percent mammographic density \[[@CR3], [@CR18], [@CR21]\], and this is possibly due to the influence of endocrine hormones and circulating growth factors, such as IGF-1 and prolactin \[[@CR21]\]. In our study, we did not observe an association between height and percent density and dense area. Interestingly, height was inversely associated with non-dense area in both premenopausal and postmenopausal women, suggesting that the positive relationship between height and percent density observed in other studies could also be a result of changes in adiposity, rather than changes in dense tissue.

Among premenopausal women, both an increasing duration of smoking and packs of cigarettes smoked per week were associated with lower percent density, while an increasing age of initiation of smoking was associated with greater dense area. Our results suggest an inverse association between smoking and mammographic density, which supports most \[[@CR22]--[@CR24]\], but not all \[[@CR25], [@CR26]\], of the existing literature. While this inverse relationship contradicts what is known about early exposure to smoking and breast cancer risk, many studies have reported positive associations between age of initiation of smoking and cigarettes smoked per day and mammographic density, in both premenopausal and postmenopausal cohorts \[[@CR22]--[@CR24]\]. Interestingly, we found that postmenopausal former smokers, but not current smokers, had higher adjusted mean percent density and dense area, and significantly lower non-dense area compared to never smokers. Similarly, two studies have observed higher percent density among both premenopausal and postmenopausal women who quit smoking compared to never smokers and current smokers \[[@CR22], [@CR23]\]. Based on these findings, the anti-estrogenic properties of tobacco may be associated with mammographic density, rather than its carcinogenic properties \[[@CR22]\], and thus, mammographic density is unlikely to mediate the effect of smoking on breast cancer risk in this cohort.

Alcohol use is positively associated with mammographic density and with breast cancer risk in the general population \[[@CR24], [@CR25], [@CR27]--[@CR29]\], likely due to its stimulatory effect on circulating estrogens and IGF-1 levels, which may increase dense epithelial cell proliferation \[[@CR28], [@CR30]\]. In our study, an increasing age of initiation of alcohol was associated with significantly greater percent density and dense area among premenopausal and postmenopausal women. Premenopausal women who first consumed alcohol after age 18 had significantly lower adjusted mean non-dense area compared to women who consumed alcohol earlier. Overall, in contrast to others, our findings suggest an inverse association between alcohol consumption and mammographic density, suggesting that mammographic density likely does not mediate the association between alcohol and breast cancer risk in this cohort.

Strengths of the current study include the novelty of the study population, which was comprised of women with a strong family history of breast cancer but no identified *BRCA* mutation in their affected relatives. Our group previously estimated that this cohort faces a lifetime risk of breast cancer of 40% by age 70 \[[@CR31]\]. Other prospective cohorts of women with a family history of breast cancer have been established \[[@CR8], [@CR32]--[@CR34]\], but there is wide variation in their family history criteria, and *BRCA* mutation status is not consistently ascertained. While other studies have included non-carriers from *BRCA* mutation-positive families \[[@CR35]\], these women may still represent a different risk profile than women from *BRCA* mutation-negative families. Therefore, our prospective cohort study based at an academic research hospital differs from other familial studies given our strict family history criteria, which considers both the relation of the affected relatives to the subject and their ages at diagnosis, and confirmation of negative *BRCA* mutation status \[[@CR9]\]. Another strength to this study is the use of the Cumulus software to assess mammographic density, which performs well against qualitative and fully-automated methods, and is currently the gold standard for measuring mammographic density \[[@CR14]\].

A primary limitation of our analysis was the small sample size, which may have limited the statistical power of our analyses, and therefore increased the likelihood of Type II error. As a result, we may have failed to observe a statistically significant association between some of the exposures of interest and the mammographic density measures. The sample size also limited our ability to test for effect modification by BMI and hormone replacement therapy use, which have been shown to be important when evaluating the associations between alcohol and mammographic density \[[@CR25]\]. Due to the low number of smokers and nulliparous women in the sample, we could not evaluate the effects of smoking and alcohol before first full-term pregnancy on mammographic density, which may be a more important risk factor than age of initiation \[[@CR22], [@CR30]\]. Moreover, only six subjects reported ever using chemopreventive drugs, and only three have taken tamoxifen, therefore the relationship between chemoprevention and mammographic density could not be evaluated. A further limitation is that the mammograms and questionnaires were completed at different time points, with the premenopausal women having a significantly greater mean time difference compared to postmenopausal women (0.9 years vs. 0.6 years; *P* = 0.01), as well as a wide range of 0 to 5.6 years. However, the mean time differences in both groups were less than one year, which highlights the uptake of intensive breast screening among this high risk cohort. Since Cumulus is an area-based technique, it is unable to consider the 3-dimensional depth (i.e., volume) of the breast \[[@CR36]\]. In addition, its reliance on a human reader is associated with the possibility of bias, although our reliability between readers was high (mean within-batch correlation coefficient: 0.91).

Conclusions {#Sec13}
===========

In this preliminary cross-sectional analysis, various risk factors were associated with mammographic density among women with a strong family history of breast cancer. Future studies including a larger sample size and a longer follow-up are needed to determine the joint effects of these risk factors and mammographic density on breast cancer risk as the primary endpoint in this high-risk cohort. If replicated in larger studies, these findings may have important implications for counselling women from high-risk families about targeting modifiable risk factors to reduce mammographic density. Further evidence may also support the inclusion of mammographic density independently of other risk factors into breast cancer risk prediction models, which are used to identify women who will benefit from high-risk breast cancer screening and primary prevention strategies.
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